Lodestar Investment Counsel Has Boosted Cisco Systems (CSCO) Holding By $300,300; Ovid Therapeutics (OVID) SI Decreased By 10.03%

February 7, 2018 - By rebbecca

Lodestar Investment Counsel Llc increased Cisco Systems (CSCO) stake by 5.34% reported in 2017Q3 SEC filing. Lodestar Investment Counsel Llc acquired 9,100 shares as Cisco Systems (CSCO)’s stock declined 7.50%. The Lodestar Investment Counsel Llc holds 179,653 shares with $6.04 million value, up from 170,553 last quarter. Cisco Systems now has $198.59 billion valuation. The stock increased 3.58% or $1.39 during the last trading session, reaching $40.17. About 55.17 million shares traded or 136.53% up from the average. Cisco Systems, Inc. (NASDAQ:CSCO) has risen 13.20% since February 7, 2017 and is uptrending. It has underperformed by 3.50% the S&P500.

Ovid Therapeutics Incorporated (NASDAQ:OVID) had a decrease of 10.03% in short interest. OVID’s SI was 309,400 shares in February as released by FINRA. Its down 10.03% from 343,900 shares previously. With 40,400 avg volume, 8 days are for Ovid Therapeutics Incorporated (NASDAQ:OVID)’s short sellers to cover OVID’s short positions. The stock decreased 1.25% or $0.1 during the last trading session, reaching $7.9. About 58,888 shares traded. Ovid Therapeutics Inc. (NASDAQ:OVID) has 0.00% since February 7, 2017 and is . It has underperformed by 16.70% the S&P500.

Among 38 analysts covering Cisco Systems Inc. (NASDAQ:CSCO), 24 have Buy rating, 0 Sell and 14 Hold. Therefore 63% are positive. Cisco Systems Inc. had 137 analyst reports since August 4, 2015 according to SRatingsIntel. The stock of Cisco Systems, Inc. (NASDAQ:CSCO) has “Overweight” rating given on Thursday, August 18 by Barclays Capital. The stock of Cisco Systems, Inc. (NASDAQ:CSCO) has “Buy” rating given on Tuesday, November 14 by Wells Fargo. On Thursday, August 18 the stock rating was maintained by Cowen & Co with “Outperform”. Barclays Capital maintained the shares of CSCO in report on Thursday, November 16 with “Buy” rating. The stock of Cisco Systems, Inc. (NASDAQ:CSCO) earned “Buy” rating by Drexel Hamilton on Thursday, August 18. RBC Capital Markets maintained Cisco Systems, Inc. (NASDAQ:CSCO) on Tuesday, June 20 with “Buy” rating. Cowen & Co maintained the stock with “Buy” rating in Thursday, November 16 report. The company was maintained on Thursday, August 13 by Goldman Sachs. On Wednesday, September 6 the stock rating was maintained by RBC Capital Markets with “Buy”. On Monday, May 15 the stock rating was upgraded by Morgan Stanley to “Overweight”.

Investors sentiment decreased to 1.02 in Q3 2017. Its down 0.16, from 1.18 in 2017Q2. It is negative, as 74 investors sold CSCO shares while 637 reduced holdings. 107 funds opened positions while 619 raised stakes. 3.60 billion shares or 0.03% more from 3.60 billion shares in 2017Q2 were reported. 435,046 were reported by Greenwich Wealth Ltd. Parkside Commercial Bank holds 23,674 shares or 0.31% of its portfolio. 15.24 million were accumulated by Sumitomo Mitsui Trust. Hexavest Inc holds 1.75% or 4.25M shares in its portfolio. Strategic Advsrs Lc owns 109,956 shares or 1.42% of their US portfolio. Abner Herrman & Brock Ltd Liability Co reported 45,655 shares. Utd Svcs Automobile Association invested in 0.83% or 8.48M shares. Diamond Hill Incorporated, Ohio-based fund reported 583,078 shares. Ruffer Limited Liability Partnership stated it has 102,830 shares or 0.15% of all its holdings. Alyeska Invest Group Inc Ltd Partnership stated it has 0.08% in Cisco Systems, Inc. (NASDAQ:CSCO). Pinnacle Inc owns 45,692 shares. Mgmt Professionals owns 2,793 shares. 4,524 were reported by Tru Asset Management Ltd. Moreover, Legacy Private has 0.27% invested in Cisco Systems, Inc. (NASDAQ:CSCO). Perritt Capital Mgmt owns 8,956 shares.

Since August 23, 2017, it had 0 buys, and 7 sales for $23.51 million activity. The insider CHAMBERS JOHN T sold 250,000 shares worth $7.79M. On Monday, September 11 the insider Walker Karen sold $740,883. 121,390 shares valued at $3.89 million were sold by Robbins Charles on Monday, September 11. Shares for $821,900 were sold by BHATT PRAT on Monday, September 11. $7.59M worth of Cisco Systems, Inc. (NASDAQ:CSCO) shares were sold by BARTZ CAROL. Another trade for 65,000 shares valued at $2.11 million was sold by CHANDLER MARK D. Another trade for 15,230 shares valued at $578,740 was sold by MCGEARY RODERICK C.

Ovid Therapeutics Inc., a biopharmaceutical company, develops impactful medicines for patients and families with neurological disorders in the United States. The company has market cap of $194.37 million. The firm is developing OV101, a drug candidate that is in Phase II clinical trial for adults with angelman syndrome; and Phase I clinical trial for adolescents with angelman syndrome or fragile X syndrome, as well as in preclinical development stage for pediatrics with angelman syndrome. It currently has negative earnings. It is also developing OV935, a drug candidate that is in Phase I trial for rare epileptic encephalopathies; preclinical-stage compounds for rare epilepsy disorders; and OV102, an intravenous formulation for indications in the hospital setting.